FFNTF (4Front Ventures) Current Ratio: 0.34 (As of Sep. 2024)


FFNTF 4Front Ventures Corp FFNTF
10 GF Score
Price $0.00
View Full Analysis

What is 4Front Ventures Current Ratio?

4Front Ventures FFNTF -90.00% 10 Current Ratio is 0.34 as of Sep. 2024. GuruFocus rates FFNTF with a GF Score™ of 10/100.

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. 4Front Ventures's current ratio for the quarter that ended in Sep. 2024 was 0.34.

4Front Ventures has a current ratio of 0.34. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If 4Front Ventures has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.

The historical rank and industry rank for 4Front Ventures's Current Ratio or its related term are showing as below:

FFNTF's Current Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.995
* Ranked among companies with meaningful Current Ratio only.

4Front Ventures  (OTCPK:FFNTF) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


4Front Ventures Current Ratio Related Terms


4Front Ventures Current Ratio Historical Data

* Premium members only.

The historical data trend for 4Front Ventures's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4Front Ventures Current Ratio Chart

4Front Ventures Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22 Dec23
Current Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.51 1.18 1.04 0.69 0.33

4Front Ventures Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.34 0.33 0.30 0.32 0.34

FFNTF vs CRYM, PNXP, SKYI: Current Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, 4Front Ventures's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


4Front Ventures Current Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, 4Front Ventures's Current Ratio distribution charts can be found below:

* The bar in red indicates where 4Front Ventures's Current Ratio falls into.


FFNTF
10GF Score
4Front Ventures Corp FFNTF
Current Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

4Front Ventures Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

4Front Ventures's Current Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Current Ratio (A: Dec. 2023 )=Total Current Assets (A: Dec. 2023 )/Total Current Liabilities (A: Dec. 2023 )
=33.912/104
=0.33

4Front Ventures's Current Ratio for the quarter that ended in Sep. 2024 is calculated as

Current Ratio (Q: Sep. 2024 )=Total Current Assets (Q: Sep. 2024 )/Total Current Liabilities (Q: Sep. 2024 )
=38.083/112.885
=0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Current Ratio →
What does a Current Ratio of 0.34 mean?
4Front Ventures (FFNTF) has a Current Ratio of 0.34 as of Sep. 2024.
Is 4Front Ventures' Current Ratio too high?
4Front Ventures' current Current Ratio is 0.34. The Drug Manufacturers industry median Current Ratio is 2.00. 4Front Ventures' value of 0.34 is 83% below this industry median. Overall, 4Front Ventures has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does 4Front Ventures' Current Ratio compare to CRYM and PNXP?
4Front Ventures' Current Ratio of 0.34 can be compared against companies in the Drug Manufacturers industry. The industry median Current Ratio is 2.00. 4Front Ventures' value of 0.34 is 83% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Drug Manufacturers company?
The median Current Ratio among Drug Manufacturers companies is 2.00, based on 998 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 4Front Ventures's current Current Ratio of 0.34 is 83% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Current Ratio is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 4Front Ventures's current Current Ratio is 0.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 4Front Ventures stock overvalued right now?
4Front Ventures (FFNTF) has a current Current Ratio of 0.34. The current Current Ratio is 0.34 and 83% below the Drug Manufacturers industry median of 2.00. 4Front Ventures' overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For 4Front Ventures (FFNTF), the current Current Ratio is 0.34 as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

4Front Ventures Business Description

Address 7010 E. Chauncey Lane, Suite 235, Phoenix, AZ, USA, 85054
4Front Ventures Corp is a Canadian-based company. It is engaged in the cultivation, processing, extracting, manufacturing, and distribution of cannabis products. It operates in two segments: THC Cannabis and CBD Wellness. The THC Cannabis segment engages in the production and cultivation of THC cannabis, manufacturing and distribution of cannabis products to owned dispensaries and third-party retail customers. The CBD Wellness segment encompasses the production and sale of CBD products to third-party customers.
10GF Score

Get the complete analysis for FFNTF

Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price